Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

SHE/300584 stock hub

SHE/300584 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

SHE/300584is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

5.1B

Shenzhen Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

SHE/300584

In the news

Latest news · SHE/300584

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 17.1P50 24.2P75 37.8

Trailing P/E114.6

P25 23.5P50 41.3P75 83.2

ROE3.9

P25 -0.9P50 4.1P75 8.8

ROIC6.1

P25 -0.5P50 5P75 11.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All SHE/300584 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

224

Groups with data

Currency

CNY

Showing 224 of 224 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	China
Country code	CN
Employees	548
Employees Change	-5%
Employees Change Percent	-0.9
Enterprise value	CNY 5.4B
Exchange	Shenzhen Stock Exchange
Financial currency	CNY
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	CNE100002F44
Last refreshed	2026-05-10
Market cap	CNY 5.1B
Price	CNY 42.4
Price currency	CNY
Rev Per Employee	1,256,816.18x
Sector	Healthcare
Sic	2834
Symbol	she/300584
Website	https://www.hicin.cn

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	0.87%
EV Earnings	120.73x
EV/EBIT	61.46x
EV/EBITDA	34.38x
EV/FCF	-1,752.58x
EV/Sales	7.78x
FCF yield	-0.06%
P/B ratio	4.56x
P/E ratio	114.63x
P/S ratio	7.39x
PE Ratio10 Y	58.88x
PE Ratio3 Y	86.61x
PE Ratio5 Y	71.09x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	12.87%
EBITDA Margin	22.56%
Gross margin	80.82%
Gross Profit	CNY 556.7M
Gross Profit Growth	21.99%
Gross Profit Growth Q	2.42%
Gross Profit Growth3 Y	13.72%
Gross Profit Growth5 Y	0.9%
Net Income	CNY 44.4M
Net Income Growth	5.94%
Net Income Growth Q	15.47%
Net Income Growth Quarters	1%
Net Income Growth Years	3%
Net Income Growth3 Y	11.47%
Net Income Growth5 Y	-2.96%
Pretax Margin	6.67%
Profit Margin	6.44%
Profit Per Employee	CNY 80,993
Profitable Years	14
ROA	3.68
Roa5y	2.3
ROCE	7.56
ROE	3.88
Roe5y	9.98
ROIC	6.11
Roic5y	4.04

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	116.74%
Cagr3y	20.95%
Cagr5y	18.57%
Div CAGR3	-26.32%
Div CAGR5	-16.74%
EPS Growth	5.96
EPS Growth Q	15.48
EPS Growth Quarters	1
EPS Growth Years	3
EPS Growth3 Y	11.48
EPS Growth5 Y	-2.96
OCF Growth	-53.73%
OCF Growth Q	-75.41%
OCF Growth10 Y	6.49%
OCF Growth3 Y	-10.64%
OCF Growth5 Y	-14.75%
Revenue Growth	26.97x
Revenue Growth Q	12.4x
Revenue Growth Quarters	7x
Revenue Growth Years	1x
Revenue Growth3 Y	11.79x
Revenue Growth5 Y	-0.39x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CNY 0.46
Assets	CNY 1.5B
Cash	CNY 71.2M
Current Assets	CNY 383.7M
Current Liabilities	CNY 359.8M
Debt	CNY 296.2M
Debt EBITDA	CNY 1.88
Debt Equity	CNY 0.27
Debt FCF	CNY -96.88
Equity	CNY 1.1B
Liabilities	CNY 415.7M
Long Term Assets	CNY 1.1B
Long Term Liabilities	CNY 55.9M
Net Cash	CNY -225M
Net Cash By Market Cap	CNY -4.42
Net Debt EBITDA	CNY 1.45
Net Debt Equity	CNY 0.2
Tangible Book Value	CNY 958.1M
Tangible Book Value Per Share	CNY 7.98
WACC	4.99

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.07
Inventory Turnover	1.53
Net Working Capital	CNY 202.2M
Quick ratio	0.79
Working Capital	CNY 23.9M
Working Capital Turnover	CNY 49.47

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.02%
Dividend Growth	100%
Dividend Growth Years	1%
Dividend per share	CNY 0.1
Dividend Years	2
Dividend Yield	0.24%
Last Dividend	CNY 0.1
Payout Ratio	43.53%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	116.63%
200-day SMA	50.27
3Y total return	76.94%
50-day SMA	43.12
50-day SMA vs 200-day SMA	50under200
5Y total return	134.32%
All Time High	87.4
All Time High Change	-51.49%
All Time High Date	2022-03-17
All Time Low	8.89
All Time Low Change	377.1%
All Time Low Date	2017-01-12
ATR	1.76
Beta	0.19
Beta1y	0.89
Beta2y	1.13
Ch YTD	-15.57
High	43.38
High52	81.88
High52 Date	2025-09-08
High52ch	-48.22%
Low	42.4
Low52	19.36
Low52 Date	2025-05-08
Low52ch	119.01%
Ma50ch	-1.68%
Price vs 200-day SMA	-15.65%
RSI	47.03
RSI Monthly	56
RSI Weekly	44.73
Sharpe ratio	1.31x
Sortino ratio	2.61
Total Return	0.26%
Tr YTD	-15.57
Tr1m	-4.01%
Tr1w	-1.26%
Tr3m	-5%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CNY 88.7M
Operating Income Growth	49.69
Operating Income Growth Q	-11.35
Operating Income Growth3 Y	36.76
Operating Income Growth5 Y	7.97
Operating margin	12.87

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	48,871,431%
Net Borrowing	16,910,000
Shares Insiders	58.37%
Shares Institutions	1.9%
Shares Out	120,000,000
Shares Qo Q	0.03%
Shares Yo Y	-0.02%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CNY -3.1M
Average Volume	4,387,501.5x
Bv Per Share	8.92
CAPEX	CNY -48.6M
Ch1m	-4.01
Ch1w	-1.26
Ch1y	116
Ch3m	-5
Ch3y	75.86
Ch5y	129.7
Ch6m	-23.71
Change	-0.73%
Change From Open	-0.66
Close	42.71
Days Gap	-0.07
Depreciation Amortization	66,744,862
Dollar Volume	116,856,520
Earnings Date	2026-04-25
EBIT	CNY 88.7M
EBITDA	CNY 155.4M
EPS	CNY 0.37
F Score	7
FCF	CNY -3.1M
FCF EV Yield	-0.06x
FCF Per Share	CNY -0.03
Financing CF	-6,484,909
Fiscal Year End	December
Founded	2,003
Graham Number	8.61719
Graham Upside	-79.68
Income Tax	CNY 3.8M
Investing CF	-19,070,173
Is Primary Listing	1
Last Earnings Date	2026-04-25
Last Report Date	2026-03-31
Last Split Date	2018-04-20
Last Split Type	Forward
Lynch Fair Value	CNY 1.85
Lynch Upside	-95.64
Ma150	50.32
Ma150ch	-15.74%
Ma20	43.01
Ma20ch	-1.43%
Net CF	19,991,605
Next Earnings Date	2026-08-21
Open	42.68
P OCF Ratio	111.7
Payment Date	2025-06-09
Position In Range	0
Ppne	869,103,852
Price Date	2026-05-08
Price EBITDA	CNY 32.74
Ptbv Ratio	5.31
Relative Volume	0.61x
Revenue	688,735,266x
Tax By Revenue	0.56x
Tax Rate	8.34%
Tr6m	-23.71%
Volume	2,756,050

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

SHE/300584 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+0.2%

$0.10 annual per share

Payout ratio

+43.5%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

-16.7%

1 consecutive years of growth

Total shareholder yield

+0.3%

Dividend yield + buyback yield combined

Performance

SHE/300584 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns SHE/300584?

Insider, institutional, and short-interest positioning.

Institutional ownership

+1.9%

Share of float held by funds and institutions

Insider ownership

+58.4%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-0.0%

Negative means the company is buying back shares.

Technical

SHE/300584 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

47.0

Neutral momentum band

Price vs 200-day MA

-15.7%

50/200-day relationship not available

Beta (5Y)

0.19

Less volatile than the market

Sharpe ratio

1.31

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About SHE/300584

Hub-level FAQ points readers to the deeper analysis pages.

What is the current she/300584 stock rating?

she/300584 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full she/300584 analysis?

The full report lives at /stocks/she/300584/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for she/300584?

The latest report frames she/300584 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the she/300584 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.